Piramal Pharma Solutions
Lexington, KY · Riverview, MI · Ahmedabad, IN
Program data pending ClinicalTrials.gov matching
· Last scored 2026-04-02
84.2
Signal Score
✓ FDA Inspections (2)
○ Clinical Trials
○ SEC Filings
✓ Press (10)
✓ EMA GMP (1)
✓ MHRA GMP (12)
Quick Facts: Piramal Pharma Solutions
- Signal Score
- 84.2/100 (as of 2026-04-02)
- Quality Compliance
- 99.9/100
- Headquarters
- Lexington, KY · Riverview, MI · Ahmedabad, IN
- Modalities
- Biologics
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
Signal Score & Pillar Breakdown
Quality Compliance
99.9
FDA Inspections2 on record
Warning Letters0
Last InspectionNo Action Indicated (NAI) (2025-05-30)
EMA GMP Certificates1 on record
MHRA GMP Certificates12 on record
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesBiologics
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
83.0
Publicly traded — financial transparency
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Publicly traded — financial transparency
Capacity
58.0
3 manufacturing sites
Sites: Lexington, KY, Riverview, MI, Ahmedabad, India
Source: SEC EDGAR, press monitoring, company profiles
3 manufacturing sites
Recent Press10 articles
3 manufacturing sites
FDA Inspection History
2025-05
2025-02
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2025-05-30 | Aurora | Drug Quality Assurance | No | No Action Indicated (NAI) |
| 2025-02-17 | Navi Mumbai | Drug Quality Assurance | No | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Apr 05, 2026
EMA GMP Compliance 1 certificates
2025-11
Compliant
Non-Compliant
| Certificate | Site | Country | Inspection Date | Status |
|---|---|---|---|---|
| NL/H 25/2059654 | Piramal Pharma Solutions (Dutch) B.V. | Netherlands | 2025-11-27 | COMPLIANT |
Source: EMA EudraGMDP · Retrieved Apr 05, 2026
MHRA GMP Compliance 12 certificates
2025-09
2025-09
2025-09
2025-09
2025-02
2025-02
2024-12
2024-12
2024-12
2024-02
2019-05
2019-05
Compliant
Non-Compliant
| Certificate | Site | City / Postcode | Inspection Date | Status |
|---|---|---|---|---|
| UK API 29595 Insp GMP/IMP 29595/10933-0018 [H] | PIRAMAL HEALTHCARE UK LIMITED | GRANGEMOUTH FK3 8XG | 2025-09-02 | COMPLIANT |
| UK API 29595 Insp GMP/IMP 29595/10933-0018 [V] | PIRAMAL HEALTHCARE UK LIMITED | GRANGEMOUTH FK3 8XG | 2025-09-02 | COMPLIANT |
| UK MIA 29595 Insp GMP/IMP 29595/10933-0018[H] | PIRAMAL HEALTHCARE UK LIMITED | GRANGEMOUTH FK3 8XG | 2025-09-02 | COMPLIANT |
| UK MIA(IMP) 29595 Insp GMP/IMP 29595/10933-0018[I] | PIRAMAL HEALTHCARE UK LIMITED | GRANGEMOUTH FK3 8XG | 2025-09-02 | COMPLIANT |
| UK GMP 18772 Insp GMP 18772/301330-0010 [H] | PIRAMAL PHARMA LIMITED | IN-502 321 | 2025-02-05 | COMPLIANT |
| UK GMP 18772 Insp GMP 18772/301330-0010 [V] | PIRAMAL PHARMA LIMITED | IN-502 321 | 2025-02-05 | COMPLIANT |
| UK API 29595 Insp GMP/GDP/IMP 29595/18244-0044 | PIRAMAL HEALTHCARE UK LIMITED | MORPETH NE61 3YA | 2024-12-23 | COMPLIANT |
| UK MIA(IMP) 29595 Insp GMP/GDP/IMP 29595/18244-0044[I] | PIRAMAL HEALTHCARE UK LIMITED | MORPETH NE61 3YA | 2024-12-23 | COMPLIANT |
| UK MIA 29595 Insp GMP/GDP/IMP 29595/18244-0044[H] | PIRAMAL HEALTHCARE UK LIMITED | MORPETH NE61 3YA | 2024-12-23 | COMPLIANT |
| UK MIA 29595 Insp GMP 29595/36189300-0002[H] | PIRAMAL HEALTHCARE UK LIMITED | GRANGEMOUTH FK3 8ZF | 2024-02-06 | COMPLIANT |
| UK GMP 54023 Insp GMP 54023/301330-0009 [H] | PIRAMAL PHARMA LIMITED | IN-502 321 | 2019-05-13 | COMPLIANT |
| UK GMP 54023 Insp GMP 54023/301330-0009 [V] | PIRAMAL PHARMA LIMITED | IN-502 321 | 2019-05-13 | COMPLIANT |
Source: MHRA GMDP Database · Retrieved Apr 05, 2026
Recent News 10 articles
Piramal Pharma Solutions commemorates 20th anniversary at Morpeth Facility with procurement of Korsch X3 - Manufacturing Chemist
Piramal Pharma Solutions commemorates 20th anniversary at Morpeth Facility with procurement of Korsch X3 Manufacturing Chemist
Piramal Pharma Solutions Commemorates 20th Anniversary at Morpeth Facility with Procurement of Korsch X3 Tablet Press - PR Newswire
Piramal Pharma Solutions Commemorates 20th Anniversary at Morpeth Facility with Procurement of Korsch X3 Tablet Press prnewswire.com
Piramal Pharma Solutions Commemorates 20th Anniversary at Morpeth Facility with Procurement of Korsch X3 Tablet Press - Bolsamania
Piramal Pharma Solutions Commemorates 20th Anniversary at Morpeth Facility with Procurement of Korsch X3 Tablet Press Bolsamania
Piramal Pharma Solutions Installs Korsch X3 Tablet Press at Morpeth Facility - Contract Pharma
Piramal Pharma Solutions Installs Korsch X3 Tablet Press at Morpeth Facility Contract Pharma
Piramal Pharma Solutions' Grangemouth, UK Facility Successfully Delivers 1,500th ADC Batch - PR Newswire
Piramal Pharma Solutions' Grangemouth, UK Facility Successfully Delivers 1,500th ADC Batch prnewswire.com
Piramal Pharma Solutions' Grangemouth, UK Facility Successfully Delivers 1,500th ADC Batch - Morningstar
Piramal Pharma Solutions' Grangemouth, UK Facility Successfully Delivers 1,500th ADC Batch Morningstar
Piramal Pharma Solutions' Grangemouth, UK Facility Successfully Delivers 1,500th ADC Batch | Corporate - EQS News
Piramal Pharma Solutions' Grangemouth, UK Facility Successfully Delivers 1,500th ADC Batch | Corporate EQS News
Piramal Pharma Solutions Completes 1,500th ADC Batch at Grangemouth Facility - Contract Pharma
Piramal Pharma Solutions Completes 1,500th ADC Batch at Grangemouth Facility Contract Pharma
EQS-News: Piramal Pharma Solutions' Grangemouth, UK Facility Successfully Delivers 1,500th ADC Batch - boerse.de - boerse.de
EQS-News: Piramal Pharma Solutions' Grangemouth, UK Facility Successfully Delivers 1,500th ADC Batch - boerse.de boerse.de
Piramal Pharma Solutions' Grangemouth, UK Facility Successfully Delivers 1,500th ADC Batch | Corporate - EQS News
Piramal Pharma Solutions' Grangemouth, UK Facility Successfully Delivers 1,500th ADC Batch | Corporate EQS News
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Pfizer CentreOne
Kalamazoo, MI · McPherson, KS
Signal Score: 91.5
Biologics, mRNA
FUJIFILM Diosynth Biotechnologies
Research Triangle, NC · Holly Springs, NC · Hillerod, DK
Signal Score: 83.5
AAV, mRNA/LNP, Biologics
Ajinomoto Bio-Pharma Services
San Diego, CA · Osaka, JP
Signal Score: 83.5
Oligonucleotide, Biologics, AAV
Lotte Biologics
Incheon, KR · Syracuse, NY
Signal Score: 82.9
Biologics, AAV
Merck KGaA / MilliporeSigma (CDMO)
Darmstadt, DE · St. Louis, MO
Signal Score: 81.8
mRNA, Biologics, Cell Therapy